The face of the patent is not the ‘‘Whole Story’’: determining effective life of a pharmaceutical patent in the United States
-
Patents Against People: How Drug Companies Price Patients out of Survival – Courtesy (Dissent)
Pharma Live, , Intellectual Property Rights, 0
As our television screens toggle between pundits squabbling over Obamacare’s insurance rules and ads for erectile dysfunction remedies, another...
-
GW Pharmaceuticals Announces Us Patent Allowance For Use Of Cannabidivarin (CBDV) In Treating Epilepsy – Courtesy( Biospace)
Pharma Live, , Intellectual Property Rights, 0
GW Pharmaceuticals plc (AIM:GWP) (Nasdaq:GWPH) (“GW”) announced that the United States Patent and Trademark Office (USPTO) has issued a...
-
Reference pricing, competition, and pharmaceutical expenditures: Theory and evidence from a natural experiment
Pharma Live, , Intellectual Property Rights, 0
1-s2-0-s0047272710001751-mainDownload
-
The effect of Paragraph IV decisions and generic entry before patent expiration on brand pharmaceutical firms
Pharma Live, , Intellectual Property Rights, 0
1-s2-0-s0167629610001219-mainDownload
-
Federal Circuit Says Regulatory Patent Term Extension Prolongs Life of Entire Patent – Courtesy(Pharma Patents)
Pharma Live, , Intellectual Property Rights, 0
POSTED BY COURTENAY C. BRINCKERHOFF ON 3 NOVEMBER 2011POSTED IN FEDERAL CIRCUIT DECISIONS;PATENT TERM EXTENSIONI wrote previously about the patentability issues raised in Genetics Institute,...
-
Pfizer Trying To Overcome Patent Cliff – Courtesy (Seeking Alpha)
Pharma Live, , Intellectual Property Rights, 0
Pfizer Inc. (NYSE:PFE) is trying to overcome the patent cliff that has seen its recent quarter results suffer by...
-
It’s not just big pharma that wants to see IPR reform in US patent legislation – By Richard Lloyd
Pharma Live, , Intellectual Property Rights, 0
For over an hour yesterday, as the Senate Judiciary Committee hearing on the recently introduced PATENT Act unfolded, it seemed like we were...
-
An exploratory analysis of patent fencing in pharmaceuticals: The case of PDE5 inhibitors
Pharma Live, , Intellectual Property Rights, 0
1-s2-0-s0048733312002582-mainDownload
![](https://ml7mn4k5dnn0.i.optimole.com/w:289/h:289/q:eco/f:best/https://interactivepharm.com/wp-content/uploads/2022/08/Show-your.jpg)